Abintus Bio
San Diego
About Abintus Bio
Abintus Bio is a preclinical stage gene therapy company that engages in the field of in vivo immune cell reprogramming. The company pursues products that modulate immune cells from within their native environment to enhance patient access and patient outcomes. It focuses on the discovery and development of a portfolio of first-in-class, product candidates that are designed to directly reprogram immune cells from within their native environment using proprietary vectors and related technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.7M
- Last round: Series Unknown (Aug 2022)
- Website: abintusbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/abintus-bio-127391 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.